AI is about to change healthcare. These 42 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
To own KBR, you need to believe in its mix of long-duration defense work and growing exposure to energy transition technologies, while accepting contract timing and funding uncertainty. The new NATO PATRIOT and U.S. Army TAGM awards modestly support the short term catalyst of converting its defense pipeline into funded backlog, but they do not remove the key risk around government budget delays, program changes and potential contract disruptions across KBR’s portfolio.
The US$208 million TAGM task order stands out here, because it reinforces KBR’s positioning on high-priority precision munitions programs that tie directly into its defense-led narrative. When viewed alongside the PATRIOT award and the USTDA-backed green ammonia Pre-FEED in Morocco, it underlines how current catalysts are concentrated in government and low carbon project wins that still depend on stable defense and infrastructure spending.
However, investors should also weigh the risk that increased regulatory and budget scrutiny on defense contracts could slow awards and funding in ways that...
Read the full narrative on KBR (it's free!)
KBR's narrative projects $8.9 billion revenue and $501.9 million earnings by 2029.
Uncover how KBR's forecasts yield a $46.57 fair value, a 23% upside to its current price.
Some of the most optimistic analysts were already penciling in roughly US$9.2 billion of revenue and about US$500 million of earnings by 2029, yet today’s contract news and the possibility of tighter defense oversight show how your view on KBR can differ sharply depending on how you judge both new awards and future scrutiny.
Explore 5 other fair value estimates on KBR - why the stock might be worth as much as 72% more than the current price!
Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.
Right now could be the best entry point. These picks are fresh from our daily scans. Don't delay:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com